rapid lateral-flow assay development

Genlantis Diagnostics, Inc., based in San Diego, California, is developing rapid multiplex lateral-flow diagnostic tests for HIV and hepatitis. Its development programs include TriQuik, a combined HIV, hepatitis C and hepatitis B screening panel, and HepBQuik, which assesses markers of hepatitis B infection, prior exposure and immunity. Both products are in development and not offered for U.S. clinical use.

Read more

analytical evaluationassay optimizationclinical performance studiesmanufacturing developmentmultiplex cassette design